Sofinnova Partners: AAVantgarde Bio appoints Ram Palanki as Chairman of its Board of Directors
MILAN, ITALY / ACCESSWIRE / March 31, 2022 / AAVantgarde Bio, a Milan-based biotechnology start-up that is developing gene therapies for inherited retinal disorders based on Adeno-Associated Viral (AAV)
Source: finanznachrichten.de